Grant of Restricted Stock Units and Warrants to Employees in Genmab
Company Announcement COPENHAGEN, Denmark; January 28, 2021 – Genmab A/S (Nasdaq: GMAB) announced today that at a board meeting the...
News
Outlook Therapeutics Announces $10.0 Million Bought Deal Offering of Common Stock
MONMOUTH JUNCTION, N.J., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a late clinical-stage biopharmaceutical company working to...
Globus Medical Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call
AUDUBON, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...
Jushi Holdings Inc. Announces Partial Redemption of Senior Secured Notes Due January 2023
BOCA RATON, Fla., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCMKTS: JUSHF),...
10x Genomics to Report Fourth Quarter and Full Year 2020 Financial Results on February 17, 2021
PLEASANTON, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for...
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science...
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial
First to Demonstrate Clinical Efficacy Against COVID-19 and Both UK and South Africa Variants Strong efficacy in Phase 3 UK...
GENFIT Announces Two Key Appointments to the Executive Committee
Lille, France; Cambridge, MA; January 28, 2021 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving...
Bellicum Reports FDA Lifted Clinical Hold on BPX-601 Phase 1/2 Clinical Trial
HOUSTON, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for...
Aziyo Biologics Announces Updated CanGaroo® Envelope Label in European Markets to Allow for Hydration in an Antibiotic Solution
SILVER SPRING, Md., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused...
AVITA Medical to Announce Fiscal Second Quarter 2021 Financial Results
VALENCIA, Calif. and MELBOURNE, Australia, Jan. 28, 2021 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative...
Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market
RUTHERFORD, N.J., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (the “Company”) (Nasdaq: CGIX), a leader in drug discovery...
Evelo Biosciences Announces Proposed Public Offering of Common Stock
CAMBRIDGE, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO) (“Evelo”), a clinical stage biotechnology company developing a...
Oncternal Therapeutics Announces the Appointment of Dr. Rosemary Mazanet to the Board of Directors
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the...
Neuronetics Announces Proposed Public Offering of Common Stock
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company...
Numi Health Announces Multi City Airport COVID Testing Program
CALGARY, Alberta, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Numi Health Inc. (“Numi” or the “Company”), Canada’s premier mobile medical services...
Adamis Pharmaceuticals Announces Proposed Public Offering of Common Stock
SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and...
Iba – Acquisition of Own Share
Tab The total number of shares purchased under this program therefore amounts to 26.074. Immediate Release – January 28th, 2021...
Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations
Exciting New Research to be Presented at International Association for the Study of Lung Cancer World Conference on Lung Cancer’s...
Biosenta Announces Note Financing
TORONTO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Biosenta Inc. (“Biosenta” or the “Company”) listed on the CSE (CSE:ZRO) announces that...